Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases

Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases

US Patent 6656946 · Granted Dec 2, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors2025
Uses of DPP IV inhibitors2024
Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors2023
Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ß-d-glucopy2023
Uses of DPP IV inhibitors2022
Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopy2022
Anti-cancer combination therapy2021
Pyridinylmethyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibit2020
Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors2020
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors2019
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives2019
4-cyano-benzyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibito2019